Cantor Fitzgerald reaffirmed its Overweight rating on Surgery Partners (NASDAQ:SGRY) with a steady price target of $36.00. The stock, which has shown significant momentum with a 20% return over the ...

The first shot taken at Medicaid, likely UnitedHealthcare coverage for Vertex's pain drug, and Optum’s wellness visit ad.

The ambulatory surgery center (ASC) industry experienced another transformative year in 2024, marked by accelerated growth, evolving case complexity, and continued regulatory shifts. Strategic ...

Discover the latest news on Smile Partners USA's recapitalization and strategic investment from a new continuation fund, supported by Silver Oak.